Article

Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar…

Biologics: Targets and Therapy · 2014 · Urbano PCM, Soccol VT, Azevedo VF

Key facts

Title Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists
First author Urbano PCM, Soccol VT, Azevedo VF
Journal Biologics: Targets and Therapy
Published Jul 31, 2014
DOI 10.2147/BTT.S57253
Devices mentioned K032380, K033011, K033223, K113556, K161192, K191781, K983221, K983359
Product codes mentioned CZP, DEW, HAW, LZO, CZW, FMF, ONB, FZY, GDG, GFJ, HRR, HWT and 4 more

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature